Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma.

Alexander CoxChenming ZhaoYuri TolkachDaniel NettersheimDoris SchmidtGlen KristiansenStefan C MuellerManuel RitterStefan HauserJoerg Ellinger

Published in: Anticancer research (2020)

MYOF may serve as a diagnostic biomarker of tumor progression and a potential therapeutic target in ccRCC.

Keyphrases